In particular, the increased expression of IL-6 associated with pathological conditions is suppressed by Si-based agents in many diseases associated with inflammation, such as renal failure, renal IR injury, IR injury during flap transplantation, UC, mother-to-child infections, and neuropathic pain [21,22,37,39,50,54,55]. This evidence concerns the gene IL6 and Renal insufficiency.